DaVita HealthCare Partners Inc (DVA)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $10.98B
Last updated: Nov 17, 2026 at 11:04 AM ET
DaVita HealthCare Partners Inc (DVA) P/E Ratio & Valuation History
DaVita HealthCare Partners (DVA) trades at 12.3x trailing earnings and 0.8x sales. Its P/E of 12.3x is below its 5-year median of 13.8x. Its forward P/E is 9.5x. The median P/E across 12 similar companies is 22.1x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 29.5% higher over the next year. Its free cash flow yield is 11.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 12.3x |
| Forward P/E | 9.5x |
| Price to sales | 0.8x |
| EV/EBITDA | 7.6x |
| Price to FCF | 8.6x |
| EV/FCF | 16.5x |
| PEG | 0.4 |
| FCF yield | 11.6% |
Historical Medians
Against its 10-year medians, its P/E is 16.3% below 14.7x and its P/S is 20.0% below 1.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 12.3x | 13.8x | 14.7x |
| P/S | 0.8x | 0.9x | 1.0x |
| P/B | N/A | N/A | 4.9x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 10.5x in 2025 to 21.0x in 2017. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $113.61 | 10.5x | 0.7x | 8.6x |
| 2024 | $149.55 | 15.3x | 1.0x | 6.1x |
| 2023 | $104.76 | 12.5x | 0.8x | 3.5x |
| 2022 | $74.67 | 12.5x | 0.6x | 3.1x |
| 2021 | $113.76 | 12.5x | 1.0x | 5.0x |
| 2020 | $117.40 | 16.2x | 1.2x | 4.7x |
| 2019 | $75.03 | 13.6x | 1.0x | 2.8x |
| 2018 | $51.46 | 14.5x | 0.8x | 1.7x |
| 2017 | $72.25 | 21.0x | 1.2x | 2.3x |
| 2016 | $64.20 | 16.6x | 1.2x | 2.2x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DVA
What is DVA's forward P/E ratio?
DaVita HealthCare Partners has a forward P/E ratio of 9.5x.
Is DVA stock overvalued?
GNG's valuation label for DVA is Undervalued. Its P/E of 12.3x compares with a median of 22.1x across 12 similar companies.
What is DVA's price to sales ratio?
DaVita HealthCare Partners has a price to sales ratio of 0.8x.
What is DaVita HealthCare Partners's average P/E ratio over 5 years?
DaVita HealthCare Partners's median P/E over the last 5 years is 13.8x, from 60 month-end values through Oct 2026.
What is DVA's PEG ratio?
DaVita HealthCare Partners has a PEG ratio of 0.4.
DVA pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors